Expression of HER2/neu Does not Correlate with Survival in Soft Tissue Sarcoma

Publisher： Karger

E-ISSN： 2296-5262|26|3|268-271

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.26, Iss.3, 2003-07, pp. : 268-271

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Soft tissue sarcoma

By Peiper Matthias   Gerber Peter Arne   Engers Rainer   Matuschek Christiane   Budach Wilfried   Gripp Stephan   Pape Hildegard   Orth Klaus   Bölke Edwin  

Wiener klinische Wochenschrift, Vol. 120, Iss. 23-24, 2008-12 ,pp. : 732-732

Springer Publishing Company

Access to resources Recommend Favorite

Chemotherapy for soft tissue sarcoma

By  

CANCER, Vol. 122, Iss. 19, 2016-10 ,pp. : 2952-2960

John Wiley & Sons Inc

Access to resources Recommend Favorite

Imaging in retroperitoneal soft tissue sarcoma

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 117, Iss. 1, 2018-01 ,pp. : 25-32

John Wiley & Sons Inc

Access to resources Recommend Favorite

Utilization pattern and survival outcomes of adjuvant therapies in high‐grade nonretroperitoneal abdominal soft tissue sarcoma: A population‐based study

By  

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 14, Iss. 1, 2018-02 ,pp. : 101-113

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinicopathologic Implications of Eukaryotic Initiation Factor 3f and Her‐2/neu Expression in Gastric Cancer

By  

CLINICAL AND TRANSLATIONAL SCIENCE (ELECTRONIC), Vol. 8, Iss. 4, 2015-08 ,pp. : 320-325

John Wiley & Sons Inc

Access to resources Recommend Favorite